Barings’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,631
| Closed | -$440K | – | 235 |
|
|
2022
Q2 | $440K | Buy |
4,631
+2,776
| +150% | +$287K | 0.02% | 211 |
|
|
2022
Q1 | $218K | Sell |
1,855
-392
| -17% | -$44K | 0.01% | 291 |
|
|
2021
Q4 | $291K | Sell |
2,247
-297
| -12% | -$34.6K | 0.01% | 326 |
|
|
2021
Q3 | $288K | Buy |
+2,544
| New | +$290K | 0.01% | 324 |
|
|
2020
Q4 | – | Sell |
-23,954
| Closed | -$1.91M | – | 481 |
|
|
2020
Q3 | $1.91M | Buy |
23,954
+18,579
| +346% | +$1.45M | 0.04% | 249 |
|
|
2020
Q2 | $1.01M | Sell |
5,375
-10,750
| -67% | -$764K | 0.03% | 286 |
|
|
2020
Q1 | $1.01M | Sell |
16,125
-4,500
| -22% | -$325K | 0.03% | 286 |
|
|
2019
Q4 | $1.6M | Buy |
20,625
+1,410
| +7% | +$110K | 0.04% | 276 |
|
|
2019
Q3 | $1.41M | Buy |
19,215
+4,521
| +31% | +$318K | 0.03% | 312 |
|
|
2019
Q2 | $904K | Buy |
14,694
+10,137
| +222% | +$613K | 0.02% | 397 |
|
|
2019
Q1 | $291K | Hold |
4,557
| – | – | 0.01% | 626 |
|
|
2018
Q4 | $232K | Sell |
4,557
-1,710
| -27% | -$86.5K | ﹤0.01% | 628 |
|
|
2018
Q3 | $363K | Hold |
6,267
| – | – | 0.01% | 687 |
|
|
2018
Q2 | $304K | Buy |
6,267
+417
| +7% | +$19.5K | ﹤0.01% | 744 |
|
|
2018
Q1 | $272K | Hold |
5,850
| – | – | ﹤0.01% | 836 |
|
|
2017
Q4 | $220K | Sell |
5,850
-19,050
| -77% | -$699K | ﹤0.01% | 910 |
|
|
2017
Q3 | $907K | Buy |
24,900
+16,200
| +186% | +$618K | 0.02% | 506 |
|
|
2017
Q2 | $343K | Buy |
+8,700
| New | +$318K | 0.01% | 711 |
|
|
2016
Q4 | – | Sell |
-26,160
| Closed | -$1.05M | – | 883 |
|
|
2016
Q3 | $1.05M | Sell |
26,160
-25,080
| -49% | -$945K | 0.03% | 429 |
|
|
2016
Q2 | $1.7M | Hold |
51,240
| – | – | 0.04% | 348 |
|
|
2016
Q1 | $1.51M | Hold |
51,240
| – | – | 0.04% | 372 |
|
|
2015
Q4 | $1.35M | Sell |
51,240
-41,820
| -45% | -$1.09M | 0.03% | 403 |
|
|
2015
Q3 | $2.21M | Sell |
93,060
-39,840
| -30% | -$962K | 0.05% | 264 |
|
|
2015
Q2 | $3.15M | Hold |
132,900
| – | – | 0.1% | 214 |
|
|
2015
Q1 | $3.15M | Buy |
132,900
+8,460
| +7% | +$190K | 0.07% | 215 |
|
|
2014
Q4 | $2.64M | Buy |
124,440
+8,100
| +7% | +$163K | 0.06% | 247 |
|
|
2014
Q3 | $1.98M | Buy |
116,340
+40,020
| +52% | +$632K | 0.04% | 311 |
|
|
2014
Q2 | $1.09M | Buy |
+76,320
| New | +$1.03M | 0.03% | 470 |
|
Other funds holding EW
Barings's EW Position: Q3 2022 in Review
Barings sold out of Edwards Lifesciences (EW) in Q3 2022, closing a stake of 4,631 shares — an estimated $440K sold.
Barings first reported a position in EW in Q2 2014 and held it in 28 quarters. The position peaked at $3.15M in Q2 2015. 1,246 funds tracked by Wall St. Rank hold EW as of Q3 2022.
- Barings reported no remaining Edwards Lifesciences position as of Q3 2022 after selling out during the quarter.
- Barings sold 4,631 Edwards Lifesciences shares in Q3 2022, an estimated $440K.
- Barings first reported a position in Edwards Lifesciences in Q2 2014 and held it in 28 quarters.
- Barings's Edwards Lifesciences position peaked at $3.15M in Q2 2015.
- 1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.
Based on Barings's 13F filing for Q3 2022, filed 14 Nov 2022.